The Financial Express

ProZyme, Inc.and BiOptic, Inc. Sign Licensing Agreement to Develop Gly-Q System for Glycan Analysis

ProZyme, Inc., manufacturer of bioreagents for glycobiology, and BiOptic Inc. of Taiwan, manufacturer of instruments for DNA analysis by capillary gel electrophoresis (CGE), today announce an ...
Business Insider

ProZyme, Inc. Launch Gly-X 2-AB Express and Gly-X InstantAB Kits for Streamlined N-Glycan Analysis

HAYWARD, Calif., June 6, 2017 /PRNewswire-iReach/ -- ProZyme, Inc., a leading manufacturer of reagents and tools for glycobiology, today announced the launch of the Gly-X™ N-Glycan Rapid Release and ...
GEN

BioSystem Development and ProZyme Couple Expertise for Glycan Sample Preparation

Partners claim new product processes hundreds of samples within hours. BioSystem Development and ProZyme are collaborating to develop new methods and systems for glycan analysis. The first product to ...
Business Wire

Agilent Technologies to Expand Biopharma Consumables Portfolio with Acquisition of ProZyme

SANTA CLARA, Calif.--(BUSINESS WIRE)--Agilent Technologies Inc. (NYSE: A) today announced that it has entered into a definitive agreement to acquire privately-held ProZyme, Inc., a leading provider of ...
Pharmabiz

ProZyme, BiOptic ink agreement to develop Gly-Q system for glycan analysis

ProZyme, Inc., manufacturer of bioreagents for glycobiology, and BiOptic Inc. of Taiwan, manufacturer of instruments for DNA analysis by capillary gel electrophoresis (CGE), announced an agreement to ...